IceCure Medical is expanding its ProSense technology adoption in Europe while seeking FDA authorization for a breast cancer treatment and planning North American commercialization.

The entities involved

• IceCure Medical →

  Nothing else this week.

• Europe →

  terrestrial continent located in north-western Eurasia

  • The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
  • The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

• Trinity Biotech announced that its Premier Hb9210™ analyser received FDA clearance and the company plans to accelerate growth across its diagnostics franchise in Europe.Aug 28
• Regentis expands its clinical trials across markets in Europe.Sep 11
• MAIA Biotechnology, Inc. is actively enrolling patients and expanding its pivotal Phase 3 clinical trials across multiple nations, including Europe, Spain, Hungary, and Portugal.Sep 23
• Clinical trial centres for the company Cocoon are located across Europe.Sep 2
• MDR/IVDR reforms require adoption by the European Parliament, referencing US FDA pre-submission meetings.Sep 17